Ethyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate → HCID 118113973, 화합물
반응식
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][C:6]([O:9][C:10]([F:13])([F:12])[F:11])=[CH:5][C:4]=1[CH2:14][NH2:15].[Br:16][C:17]1[CH:18]=[CH:19][C:20]2[N:21]([CH:23]=[C:24]([C:26](OCC)=[O:27])[N:25]=2)[CH:22]=1>>[Br:16][C:17]1[CH:18]=[CH:19][C:20]2[N:21]([CH:23]=[C:24]([C:26]([NH:15][CH2:14][C:4]3[CH:5]=[C:6]([O:9][C:10]([F:12])([F:11])[F:13])[CH:7]=[CH:8][C:3]=3[O:2][CH3:1])=[O:27])[N:25]=2)[CH:22]=1참가 물질
3
실험 절차
The title compound was prepared by essentially following the same procedures described for Intermediate I, using (2-methoxy-5-(trifluoromethoxy)phenyl)methanamine and ethyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate as starting materials.
출처 및 근거
- ORD 기록
- ord-309cbe5e73944bed986c6e7c64be869b
- 출처 데이터셋
- uspto-grants-2016_03
- 특허 번호
- US09271969B2
반응 노트
불러오는 중…